GSE1926 also compared the carboplatin sensitive and resistant primary ovarian cancer cells from patients [41], and the result showed that TET3 is dramatically up-regulated in carboplatin resistant cells (P = 3.26–05, logFC = 0.48, data not shown). The gene discussed is TET3; the disease is ovarian cancer.